Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $105.60 and last traded at $105.60, with a volume of 114 shares. The stock had previously closed at $95.79.
Pharma Mar Trading Down 3.3 %
The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The stock has a 50 day moving average of $89.72 and a 200-day moving average of $72.20.
Pharma Mar Company Profile
(
Get Free Report)
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Recommended Stories
Before you consider Pharma Mar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.
While Pharma Mar currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
